Medpace Holdings (MEDP) Return on Equity (2016 - 2026)

Medpace Holdings (MEDP) has reported Return on Equity for 11 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Equity was 0.01% for Q1 2026 at Medpace Holdings, down from 0.01% in the prior quarter.
• Over five years, Return on Equity peaked at 0.02% in Q3 2025 and troughed at 0.0% in Q1 2022.
• Average Return on Equity over 5 years is 0.01%, with a median of 0.01% recorded in 2023.
• The widest YoY moves for Return on Equity: up 1 bps in 2022, down 0 bps in 2022.
• Over 5 years, Return on Equity stood at 0.01% in 2022, then decreased by 18 bps to 0.01% in 2023, then slipped by 14 bps to 0.0% in 2024, then surged by 153 bps to 0.01% in 2025, then declined by 27 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Equity figures were 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.